Amyloid MS: Analytical Methods for Early Detection of Alzheimer’s Disease from Blood. The implementation of a peptide biomarker assay to be used in clinical research.

Amyloid MS: Analytical Methods for Early Detection of Alzheimer’s Disease from Blood. The implementation of a peptide biomarker assay to be used in clinical research.

Amyloid MS: Analytical Methods for Early Detection of Alzheimer’s Disease from Blood. The implementation of a peptide biomarker assay to be used in clinical research. (#Omics12)

Chris Bowen ¹

Shimadzu Scientific, Ermington, NSW, Australia

Given the progressively aging populations in recent years, the number of dementia patients has been increasing. In some countries one in seven people aged 65 or older have dementia, and the number is expected to increase further in the future. Measures to address dementia have become a social issue and consequently there is a need to establish methods for early detection, treatment, and prevention. Though a variety of diseases can cause dementia, Alzheimer’s dementia accounts for the highest number of patients, accounting for about 60 % of the total. This presentation will give an overview of a validated non-invasive test using automated immunoprecipitation and simple MALDI TOF analysis.

#AusPeptide2023

Authors contributing to this presentation.

Bowen, C

Chris Bowen, is Shimadzu Australasia’s Mass Spectrometry Business Development Manager. After graduating in Chemistry from the University of Hertfordshire in 2000 Chris started his career in the UK then has worked in both Singapore and Australia, and with an honorary position at the University of Melbourne in 2011 working with metabolomics. Chris has over 15 years’ experience using GC/LC/MALDI Mass Spectrometer systems, working on applications ranging from small molecule GLP registration, environmental & food contaminant quantitation, to biomarker discovery and compound characterization. In recent years his focus has been on method development & metabolomics workflows. Based at the Bio21 Institute Chris has access to the very latest Shimadzu mass spectrometry systems using them to help answer researcher’s questions from experimental design, data acquisition to statistical analysis and visualization of large data sets. Chris’s main focus is on providing workflow solutions to customers in the Australasia region, plus supporting sales and applications.

Amyloid MS: Analytical Methods for Early Detection of Alzheimer’s Disease from Blood. The implementation of a peptide biomarker assay to be used in clinical research. (#Omics12)

Add notes

Bowen, C

Login